The Division of Microbiology and Infectious Diseases (DMID) supports extramural research to control and prevent diseases caused by virtually all human infectious agents except HIV. DMID provides funding opportunities and a comprehensive set of resources for researchers that support basic research, preclinical development, and clinical evaluation.
Emily Erbelding, M.D., M.P.H.
What's New:
Latest News Releases
-
NIH Statement on World Tuberculosis Day, March 24, 2018, March 22, 2018
-
H7N9 Influenza Vaccine Clinical Trials Begin, March 15, 2018
-
NIAID Unveils Strategic Plan for Developing a Universal Influenza Vaccine, February 28, 2018
For Researchers
NIAID and NIH offer a number of funding opportunities, including grants and contracts to conduct basic research, preclinical development, or clinical evaluation.
Potential Funding Opportunities:
NIAID partners with leaders in the field of infectious disease research to better understand the diseases and move forward toward better prevention, diagnosis, and treatment.
DMID supports a comprehensive set of resources for researchers. Their purpose is to facilitate the preclinical and clinical research needed to translate the ideas generated through basic research into safe and effective drugs, vaccines, and diagnostics to control and prevent infectious diseases.
Policies and procedures are essential to any clinical research enterprise. In this regard, the Division of Microbiology and Infectious Diseases has standardized and harmonized operational procedures across research areas.